Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;53(4):167-70.
doi: 10.4103/0019-5154.44786.

Deflazacort versus other glucocorticoids: a comparison

Affiliations

Deflazacort versus other glucocorticoids: a comparison

Surajit Nayak et al. Indian J Dermatol. 2008.

Abstract

Steroids form an important component of dermatological therapy and are used since very long time for different conditions in different forms. Though very few molecules are used since very long time, the side effect associated with this group of drugs are almost always there. Recently a new molecule deflazacort has been introduced into Indian market, is a glucocorticoid and a derivative of old molecule prednisolone. Though claimed to be having less side effect, very few studies have been done in Indian prospective. This review will highlight the very basics of this drug and its advantages and disadvantages.

Keywords: Deflazacort; glucocorticoids; topical therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

References

    1. Anon. Deflazacort UKDI New Medicines on the Market 4/98/02 Jan1998.
    1. Assandri A, Buniva G, Martinelli E, Perazzi A, Zerelli L. Pharmacokinetics and metabolism of deflazacort in the rat, dog, monkey and mean. Adv Exp Med Biol. 1984;71:9–23. - PubMed
    1. Coirini H, Flores D, Vega CM, Gonzalez Deniselle MC, De Nicola AF. Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo A-D in vitro studies. J Steroid Biochem Mol Biol. 1994;49:43–9. - PubMed
    1. Scudeletti M, Pende D, Barabino A, Imbimbo B, Grifoni V, Indiveri F. Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions: Analysis with monoclonal antibodies. Adv Exp Med Biol. 1984;171:335–44. - PubMed
    1. Avioli LV. Potency ratio-a brief synopsis. Br J Rheumatol. 1993;32:24–6. - PubMed

LinkOut - more resources